Dáil Éireann Debate, Wednesday - 25 March 2026
413. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to calls to allow for the provision of veoza (fezolinetant) under the drug payment scheme; and if she will make a statement on the matter. [22853/26]
View answerUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
